# OnCo record sandra-swain (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/sandra-swain/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "sandra-swain" ;
  schema:name "Sandra M. Swain"@en ;
  schema:description "Led CLEOPATRA, which showed dual HER2 blockade with pertuzumab gives an unprecedented 16-month survival gain in metastatic disease."@en ;
  schema:url <https://onco.cc/people/sandra-swain/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Sandra_M._Swain>, <https://orcid.org/0000-0002-1320-3830> ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Swain%20SM%5BAuthor%5D%20pertuzumab> ;
  onco:tag "breast", "her2", "trialist" ;
  schema:jobTitle "Professor of Medicine and Associate Dean for Research Development, Georgetown University Medical Center" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/cardio-oncology/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/> ;
  onco:institutions <https://onco.cc/institutions/georgetown-lombardi/> ;
  onco:trials <https://onco.cc/trials/cleopatra/> ;
  schema:affiliation <https://onco.cc/institutions/georgetown-lombardi/> .
